CARLO BAYRAKDARIAN: Open Payments
NPI 1356348536 · WHITE PLAINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,745 in 123 payments from 11 companies in 2025. Trend: 2023 $12,079 · 2024 $29,686 · 2025 $22,745
Speaker / faculty: $10,267Food & beverage: $5,976Honoraria: $5,500Travel & lodging: $890Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $11,538 |
| Axsome Therapeutics, Inc. | 31 | $6,948 |
| ABBVIE INC. | 25 | $1,157 |
| E.R. Squibb & Sons, L.L.C. | 12 | $858 |
| Lilly USA, LLC | 5 | $621 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $419 |
| Janssen Pharmaceuticals, Inc | 3 | $416 |
| Teva Pharmaceuticals USA, Inc. | 10 | $372 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $170 |
| Grifols USA, LLC | 1 | $125 |
Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, KISUNLA, CAPLYTA, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
